David Hochman, Director at Corbus Pharmaceuticals, holds 902.14K shares in Orchestra BioMed Holdings (Ticker: OBIO), holds 2.47M shares in Motus Gi Holdings (Ticker: MOTS), holds 1.05M shares in Corbus Pharmaceuticals (Ticker: CRBP). Most recently, David Hochman Bought ― shares of Orchestra BioMed Holdings on Jun 26, 2024 for an estimated value of 6.95K.